AvePoint has deepened its 25-year partnership with Microsoft to help organizations deploy and govern AI technologies securely and efficiently. The collaboration focuses on integrating AvePoint's governance and resilience solutions with Microsoft's AI platforms like Copilot and Agent 365, addressing challenges in AI adoption such as data security and operational control. This expanded partnership aims to enable enterprises to scale AI innovation confidently while maintaining oversight and risk management. AvePoint will continue innovating alongside Microsoft, supporting customers in maximizing AI investments and governance at the upcoming Microsoft Ignite event.
AvePoint's expanded partnership with Microsoft is presented here with Pluang's Technology-sector market data as of Nov 10, 2026 20:03 WIB. Of 150 priced Technology-sector US stocks tradable on Pluang, 40 rose and 101 fell today. Notable movers include GRAB at USD 3.23 with a 1-day change of -6.10% and a Pluang order activity of 99% Sell / 1% Buy, QUBT at USD 6.45 down 5.98%, and IONQ at USD 33.30 down 5.77%.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
